Good health is a crucial part of well-being but spending on health can be justified on economic grounds. The goal of reducing poverty provides a different but equally powerful case for health investments. However, if policymakers are to accelerate the substantial health gains of recent decades,...

GOOD HEALTH IS A CRUCIAL PART OF WELL-BEING BUT SPENDING ON HEALTH CAN BE JUSTIFIED ON ECONOMIC GROUNDS. THE GOAL OF REDUCING POVERTY PROVIDES A DIFFERENT BUT EQUALLY POWERFUL CASE FOR HEALTH INVESTMENTS. HOWEVER, IF POLICYMAKERS ARE TO ACCELERATE THE SUBSTANTIAL HEALTH GAINS OF RECENT DECADES,...

The incentive contracts that managed care organizations write with physicians have generated considerable controversy. Critics fear that if informational asymmetries inhibit patients from directly assessing the quality of care provided by their physician, competition will lead to a "race to the...

The discussion about health care systems focuses on the dynamics of expenditures and on the weak growth of revenues. In this discussion it is widely overseen that medical expenditures and the supply of medical services depend crucially on the compensation of physician services. The paper...

The Law of One Price (LoOP) states that all firms face the same prices for their inputs and outputs in the competitive market equilibrium. This law has powerful implications for productive efficiency analysis, which have remained unexploited thus far. This paper shows how LoOP-based weight...

We discuss the nonparametric approach to profit efficiency analysis at the firm and industry levels in the absence of complete price information, and propose two new insights. First, choosing one commodity (whose price is known) as a numeraire good enables us to measure profit inefficiency in...

Patenting may speed up genetic research when small inventors face high research and development costs and also face large rivals that produce at declining marginal costs. Even with patents, however, small inventors may turn down socially beneficial projects when they believe that R&D spending...

The diffusion of health care technology is influenced by both the total market share of managed care organizations as well as the level of competition among them. This paper differentiates between HMO penetration and competition and examines their relationship to the adoption of cardiac...

To judge a health care system, it is necessary to analyse its results in terms of health and to bring them back to its economic effectiveness. Health outcomes can be evaluated in several ways but none of them is really representative. To locate the performance in terms of health for the French...

The study of the stylized facts of economic growth has allowed an advance of this field of economic analysis in its empirical and theorical works. Today, Health Economics is faced with new requirements of society, i.e. better care at a sustainable cost. Furthermore, since the problems linked...